Assessment of intact fibroblast growth factor 23 in patients with heart failure with reduced ejection fraction

被引：0
|
作者：
Gruson, D. Damien [1 ]
Ahn, S. [1 ]
Ferracin, B. [1 ]
Rousseau, M. [1 ]
机构：
[1] St Luc Univ Clin, Brussels, Belgium
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1170
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [1] Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
    Vergaro, Giuseppe
    Del Franco, Annamaria
    Aimo, Alberto
    Gentile, Francesco
    Castiglione, Vincenzo
    Saponaro, Federica
    Masotti, Silvia
    Prontera, Concetta
    Fusari, Niccolo
    Emdin, Michele
    Passino, Claudio
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [2] Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
    Giuseppe Vergaro
    Annamaria Del Franco
    Alberto Aimo
    Francesco Gentile
    Vincenzo Castiglione
    Federica Saponaro
    Silvia Masotti
    Concetta Prontera
    Niccolò Fusari
    Michele Emdin
    Claudio Passino
    BMC Cardiovascular Disorders, 23
  • [3] Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fraction
    Gruson, Damien
    Ferracin, Benjamin
    Ahn, Sylvie A.
    Rousseau, Michel F.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 248 : 270 - 273
  • [4] FIBROBLAST GROWTH FACTOR 23 AND HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Ghuman, Jasleen
    Cai, Xuan
    Hecktman, Jonathan
    Shah, Sanjiv
    Wolf, Myles
    Isakova, Tamara
    Mehta, Rupal
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 675 - 675
  • [5] Fibroblast growth factor 23 is an independent and specific predictor of mortality in patients with heart failure and reduced ejection fraction
    Koller, L.
    Kleber, M. E.
    Brandenburg, V. M.
    Goliasch, G.
    Scharnagl, H.
    Grammer, T. B.
    Tomaschitz, A.
    Huelsmann, M.
    Maerz, W.
    Niessner, A.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1201 - 1201
  • [6] Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction
    Koller, Lorenz
    Kleber, Marcus E.
    Brandenburg, Vincent M.
    Goliasch, Georg
    Richter, Bernhard
    Sulzgruber, Patrick
    Scharnagl, Hubert
    Silbernagel, Guenther
    Grammer, Tanja B.
    Delgado, Graciela
    Tomaschitz, Andreas
    Pilz, Stefan
    Berger, Rudolf
    Moertl, Deddo
    Huelsmann, Martin
    Pacher, Richard
    Maerz, Winfried
    Niessner, Alexander
    CIRCULATION-HEART FAILURE, 2015, 8 (06) : 1059 - 1067
  • [7] Determinant factors of plasma fibroblast growth factor 23 levels in patients with heart failure patients with reduced ejection fraction
    Gruson, D. Damien
    Pouleur, A. C.
    Ahn, S. A.
    Rousseau, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 74 - 74
  • [8] Fibroblast Growth Factor-23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
    Almahmoud, Mohamed Faher
    Soliman, Elsayed Z.
    Bertoni, Alain G.
    Kestenbaum, Bryan
    Katz, Ronit
    Lima, Joao A. C.
    Ouyang, Pamela
    Miller, Elliott
    Michos, Erin D.
    Herrington, David M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (18):
  • [9] The ratio of fibroblast growth factor 23 to phosphorus as a predictor of cardiovascular death in heart failure patients with reduced ejection fraction.
    Gruson, D. Damien
    Ahn, S. A.
    Carbone, V.
    Rousseau, M. F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 221 - 221
  • [10] Association of the Ratio of Intact-to-C-terminal Fibroblast Growth Factor 23 with Heart Failure with Preserved Ejection Fraction
    Robinson-Cohen, Cassianne
    Perwad, Farzana
    Ix, Joachim H.
    David, Valentin
    Akwo, Elvis Abang
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
12345